Regional volume analysis of the Parkinson disease brain in early disease stage: Gray matter, white matter, striatum, and thalamus

American Journal of Neuroradiology

Volumn 32, Issue 4, 2011, Pages 682-687

  Lee, S H ^a   Kim, Sam Soo ^a   Tae, W S ^a   Lee, S Y ^a   Choi, J W ^a   Koh, S B ^b   Kwon, D Y ^b  

^a Kangwon National University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE CLASSIFICATION; FEMALE; GRAY MATTER; HUMAN; INTRACRANIAL VOLUME; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NIGRONEOSTRIATAL SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PUTAMEN; THALAMUS; WHITE MATTER;

AGED; CAUDATE NUCLEUS; CORPUS STRIATUM; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; GLOBUS PALLIDUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; NEURONS; PARKINSON DISEASE; PUTAMEN; THALAMUS;

EID: 79954479115     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2372     Document Type: Article

References (45)

1. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 1966;18:925-64
2. Braak H, Ghebremedhin E, Rub U, et al. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004;318:121-34 (Pubitemid 39362633)
3. Double KL, Halliday GM, McRitchie DA, et al. Regional brain atrophy in idiopathic Parkinson's disease and diffuse Lewy body disease. Dementia 1996;7:304-13 (Pubitemid 26341259)
4. Jellinger KA. Pathology of Parkinson's disease: changes other than the nigrostriatal pathway. Mol Chem Neuropathol 1991;14:153-97
5. Foltynie T, Brayne CE, Robbins TW, et al. The cognitive ability of an incident cohort of Parkinson's patients in the UK: the CamPaIGN study. Brain 2004;127:550-60 (Pubitemid 38295472)
6. Hu MT, White SJ, Chaudhuri KR, et al. Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm 2001;108:571-80 (Pubitemid 32441872)
7. Burton EJ, McKeith IG, Burn DJ, et al. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004;127:791-800 (Pubitemid 38478524)
8. Karagulle Kendi AT, Lehericy S, Luciana M, et al. Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol 2008;29:501-05 (Pubitemid 351424064)
9. Krabbe K, Karlsborg M, Hansen A, et al. Increased intracranial volume in Parkinson's disease. J Neurol Sci 2005;239:45-52 (Pubitemid 41617414)
10. Paviour DC, Price SL, Jahanshahi M, et al. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006;21:989-96
11. Geng DY, Li YX, Zee CS. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease. Neurosurgery 2006;58:256-62
12. Gattellaro G, Minati L, Grisoli M, et al. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol 2009;30:1222-26
13. Lewis SJ, Barker RA. Understanding the dopaminergic deficits in Parkinson's disease: insights into disease heterogeneity. J Clin Neurosci 2009;16:620-25
14. Stephens B, Mueller AJ, Shering AF, et al. Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 2005;132:741-54
15. Henderson JM, Carpenter K, Cartwright H, et al. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain 2000;123:1410-21 (Pubitemid 30420941)
16. Henderson JM, Carpenter K, Cartwright H, et al. Degeneration of the centre median-parafascicular complex in Parkinson's disease. Ann Neurol 2000;47:345-52 (Pubitemid 30141844)
17. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42
18. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467-86 (Pubitemid 36656531)
19. Poewe W, Wenning G. The differential diagnosis of Parkinson's disease. Eur J Neurol 2002;9:23-30 (Pubitemid 35471980)
20. Yushkevich PA, Piven J, Hazlett HC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 2006;31:1116-28 (Pubitemid 43851334)
21. Duvernoy HM. The Human Brain: Surface, Three-Dimensional Sectional Anatomy, and MRI. New York: Springer-Verlag; 1991
22. Kruggel F. MRI-based volumetry of head compartments: normative values of healthy adults. Neuroimage 2006;30:1-11 (Pubitemid 43243193)
23. Lemieux L, Hammers A, Mackinnon T, et al. Automatic segmentation of the brain and intracranial cerebrospinal fluid in T1-weighted volume MRI scans of the head, and its application to serial cerebral and intracranial volumetry. Magn Reson Med 2003;49:872-84 (Pubitemid 36523474)
24. MacLullich AM, Ferguson KJ, Deary IJ, et al. Intracranial capacity and brain volumes are associated with cognition in healthy elderly men. Neurology 2002;59:169-74 (Pubitemid 34779172)
25. Wolf H, Kruggel F, Hensel A, et al. The relationship between head size and intracranial volume in elderly subjects. Brain Res 2003;973:74-80 (Pubitemid 36566295)
26. Eritaia J, Wood SJ, Stuart GW, et al. An optimized method for estimating intracranial volume from magnetic resonance images. Magn Reson Med 2000;44:973-77
27. Ashburner J, Friston KJ. Voxel-based morphometry: the methods. Neuroimage 2000;11:805-21
28. Cuadra MB, Cammoun L, Butz T, et al. Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Trans Med Imaging 2005;24:1548-65 (Pubitemid 41812023)
29. Pell GS, Briellmann RS, Chan CH, et al. Selection of the control group for VBM analysis: influence of covariates, matching and sample size. Neuroimage 2008;41:1324-35
30. Beyer MK, Janvin CC, Larsen JP, et al. A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 2007;78:254-59 (Pubitemid 46579662)
31. Summerfield C, Junque C, Tolosa E, et al. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 2005;62:281-85 (Pubitemid 40204750)
32. Lewis MM, Smith AB, Styner M, et al. Asymmetrical lateral ventricular enlargement in Parkinson's disease. Eur J Neurol 2009;16:475-81
33. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003;2:229-37 (Pubitemid 37443310)
34. Jernigan TL, Archibald SL, Fennema-Notestine C, et al. Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol Aging 2001;22:581-94 (Pubitemid 32607743)
35. Aarsland D, Andersen K, Larsen JP, et al. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 2001;56:730-36 (Pubitemid 32240091)
36. Aarsland D, Tandberg E, Larsen JP, et al. Frequency of dementia in Parkinson disease. Arch Neurol 1996;53:538-42 (Pubitemid 26177134)
37. Jellinger KA. The pathology of Parkinson's disease. Adv Neurol 2001;86:55-72
38. Portas CM, Goldstein JM, Shenton ME, et al. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry 1998;43:649-59 (Pubitemid 28222385)
39. Kumar A, Mann S, Sossi V, et al. [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease. Brain 2003;126(pt 12):2648-55. Epub 2003 Aug 22 (Pubitemid 37463084)
40. Eidelberg D, Moeller JR, Dhawan V, et al. The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies. Mov Disord 1990;5:203-13 (Pubitemid 20311769)
41. Morrish PK, Sawle GV, Brooks DJ. Clinical and [18F] dopa PET findings in early Parkinson's disease. J Neurol Neurosurg Psychiatry 1995;59:597-600
42. Tatsch K, Schwarz J, Mozley PD, et al. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography. Eur J Nucl Med 1997;24:415-21 (Pubitemid 27183046)
43. Kulisevsky J, Pagonabarraga J. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Mov Disord 2009;24:1103-10
44. Riedel O, Klotsche J, Spottke A, et al. Cognitive impairment in 873 patients with idiopathic Parkinson's disease: results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol 2008; 255:255-64. Epub 2008 Jan 22
45. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-84